Filing Details
- Accession Number:
- 0001209191-20-030464
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-19 16:21:25
- Reporting Period:
- 2020-05-15
- Accepted Time:
- 2020-05-19 16:21:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Transaction Summary
| Sold: | 82 shares | Avg. Price: $284.37 | Total Value: $23,318.29 |
| Number of Shares After Transactions: | 28,902 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-05-15 | 2 | $274.98 | 28,982 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 4 | $276.44 | 28,978 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 5 | $279.48 | 28,973 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 9 | $280.47 | 28,964 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 4 | $281.55 | 28,960 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 6 | $282.77 | 28,954 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 3 | $283.74 | 28,951 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 5 | $284.98 | 28,946 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 10 | $286.12 | 28,936 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 15 | $287.19 | 28,921 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-15 | 19 | $288.05 | 28,902 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $274.98 (range $274.67 to $275.28).
- Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $276.44 (range $276.23 to $276.75).
- Open market sales reported on this line occurred at a weighted average price of $279.48 (range $278.84 to $279.82).
- Open market sales reported on this line occurred at a weighted average price of $280.47 (range $280.21 to $280.68).
- Open market sales reported on this line occurred at a weighted average price of $281.55 (range $281.24 to $282.20).
- Open market sales reported on this line occurred at a weighted average price of $282.77 (range $282.36 to $283.28).
- Open market sales reported on this line occurred at a weighted average price of $283.74 (range $283.44 to $284.05).
- Open market sales reported on this line occurred at a weighted average price of $284.98 (range $284.56 to $285.43).
- Open market sales reported on this line occurred at a weighted average price of $286.12 (range $285.60 to $286.43).
- Open market sales reported on this line occurred at a weighted average price of $287.19 (range $286.61 to $287.60).
- Open market sales reported on this line occurred at a weighted average price of $288.05 (range $287.70 to $288.47).
Billionaire Hedge Funds
